DEPRESSIONS IN EPILEPSIA: PREVALENCE, RISK FACTORS, SYMPTOMS AND THERAPY
https://doi.org/10.17749/2077-8333.2017.9.3.047-053
Abstract
The paper reviews the current data on the risk factors, pathogenesis, psychopathological symptoms and therapy of depression in patients with epilepsy. Depression predominantly occurs in patients with temporal epilepsy. The lateralization of the focus cannot be readily interpreted, although the literature indicates that depression occurs more often with left-sided foci. In their external manifestations, the episodes of depression in epilepsy can be fully the same as in any affective disorder. Treatment of depression is carried out without canceling therapy with antiepileptic drugs; the latter may have different impacts on the course of depression. In this respect, valproate, carbamazepine, oxcarbazepine, and lamotrigine do not exacerbate depression. All of them, despite the differences in their mechanisms of action, have a common component – an increase in the serotonin level in the central nervous system. Among the drugs listed above, valproate is especially beneficial.
About the Authors
V. V. Kalinin
Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky, Health Ministry of Russian Federation
Russian Federation
Russian Federation
MD, Professor, Head of the Department of exogenous-organic disorders and epilepsy, the Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky. Address: ul. Poteshnaya, 3, Moscow, Russia, 107076
E. V. Zheleznova
Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky, Health Ministry of Russian Federation
Russian Federation
Russian Federation
MD, Leading Researcher at the Department of exogenous-organic disorders and epilepsy, the Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky. Address: ul. Poteshnaya, 3, Moscow, Russia, 107076
A. A. Zemlyanaya
Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky, Health Ministry of Russian Federation
Russian Federation
Russian Federation
PhD, Senior Researcher at the Department of exogenous-organic disorders and epilepsy, the Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky. Address: ul. Poteshnaya, 3, Moscow, Russia, 107076
L. V. Sokolova
Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky, Health Ministry of Russian Federation
Russian Federation
Russian Federation
PhD, Senior Researcher at the Department of exogenous-organic disorders and epilepsy, the Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky. Address: ul. Poteshnaya, 3, Moscow, Russia, 107076
K. Yu. Subbotin
Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky, Health Ministry of Russian Federation
Russian Federation
Russian Federation
Junior Researcher at the Department of exogenous-organic disorders and epilepsy, the Federal Medical Research Centre for Psychiatry and Narcology named after V. P. Serbsky. Address: ul. Poteshnaya, 3, Moscow, Russia, 107076
References
1. Kanner A. Depression in neurological disorders. Lundbeck Institute, Cambridge Medical Communication Ltd. 2005; 161 p.
2. Kanner A. Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy. Epilepsia. 2004; 45 (2): 22-27.
3. Forsgren L., Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Research. 1990; 6: 66-81.
4. Hesdorffer D. C., Hauser W. A., Annegers J. F. et al. Major depression is a risk factor for seizures in older adults. Ann Neurology. 2000; 47: 246-249.
5. Perini G. I., Tosin C., Carraro C. et al. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 1996; 61 (6): 601-605.
6. Quiske A., Helmstaedter C., Lux S. et al. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Research. 2000; 39: 121-125.
7. Blumer D. Postictal depression: significance for the neurobehavioral disorder of epilepsy. Epilepsy. 1992; 5: 214-219.
8. Blumer D. P. Interictal Dysphoric Disorder In: Behavioral aspects of epilepsy. Principles and practice (Eds. S. C. Schachter, G. L. Holmes, D.G.A. Kasteleijn-Nolst Trenite). New York. 2008; 209-217.
9. Mendez M. F., Cummings J. L., Benson D. F. Depression in epilepsy. Significance and phenomenology. Arch Neurology. 1986; 43: 766-770.
10. Victoroff J. I., Benson F., Grafton S. T. et al. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol. 1994, 51: 155-163.
11. Flor-Henry P. Psychosis and temporal lobe epilepsy: a controlled investigation. Epilepsia. 1969; 10: 363-395.
12. Kalinin V. V., Polyanskiy D. A. Focus laterality and interictal psychiatric disorder in temporal lobe epilepsy. Seizure. 2009; 18 (3): 176-179.
13. Manchanda R., Schaefer B., McLachlan et al. Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry. 1996; 61 (1): 82 -89.
14. Kalinin V. V., Zemlyanaya A. A., Krylov O. E., Zheleznova E. V. Handedness, alexithymia, and focus laterality as risk factors for psychiatric comorbidity in patients with epilepsy. Epilepsy & Behavior. 2010; 17 (3): 389-394.
15. Asberg M., Thoren P., Traskman L. et al. “Serotonin depression” – a biochemical subgroup within the affective disorder? Science. 1976; 191: 478-480.
16. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 1976; 33: 1193-1197.
17. Brown G. L., Ebert M. E., Goyer P. F. et al. Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am.J.Psychiatry. 1982; 139: 741-746.
18. Brown G. L., Goodwin F. K., Ballenger J. C. et al. Aggression in human correlates with cerebrospinal fluid metabolites. Psychiatry Res. 1979; 1: 131-139.
19. Maynert E., Marczynski T., Browning R. The role of neurotransmitters in the epilepsies. Adv Neurology. 1975; 13: 79-n147.
20. Chugani H. T., Chugani D. C. Imaging of serotonin mechanisms in epilepsy. Epilepsy Currents. 2005; 5 (6): 201-206.
21. Dailey J. W., Reigel C. E., Mishra P. K. et al. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Research. 1989; 3: 317-320.
22. Statnick M. A., Daile J. W., Jobe P. C. et al. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia. 1996; 37: 311-321.
23. Louw D., Sutherland G. B., Glavin G. B. et al. A study of monoamine metabolism in human epilepsy. Can J Neurol Sci. 1989; 16: 394 397.
24. Drevets W. C., Frank E., Price J. C. et al. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry. 1999; 46: 1375-1387.
25. Gilliam F., Santos J., Vahle V. et al. Depression in Epilepsy: Ignoring clinical expression of neuronal network dysfunction? Epilepsia. 2004; 45 (2): 28-33.
26. Kanner A., Nieto J. Depressive disorders in epilepsy. Neurology. 1999; 53 (2): 26-32.
27. Attarian H., Vahle V., Carter J., Hykes E., Gilliam F. Relation between Depression and Intractability of Seizures. Epilepsy & Behav. 2003; 4: 298-301.
28. Kalinin V. V., Zheleznova E. V., Sokolova L. V., Zemlyanaya A. A., Subbotin K. Y. Focus laterality and interface between depression and anxiety in patients with temporal lobe epilepsy. Epileptology. The modern state of science. 2016; 145-155.
29. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harvard Rev Psychiatry. 2000; 8 (1): 8-17.
30. Kalinin V. V. Suicidality and antiepileptic drugs. Is there a link? Drug Safety. 2007; 30 (2): 123-142.
31. Kalinin V., Polyanskiy D. Gender differences in risk factors of suicidal behavior in epilepsy. Epilepsy & Behavior. 2005; 6: 424-429.
32. Kowski A. B., Weissinger F., Gaus V., Fidzinski P., Losch F., Holtkamp M. Specific adverse efcts of antiepileptic drugs – A true-to-life monotherapy study. Epilepsy & Behavior. 2016; 54: 150-157.
33. Wieshmann U. C., Baker G. Efficacy and tolerability of anti-epileptic drugs- an internet study. Acta Neurol Scand. 2017; 135: 533-539.
Review
For citations:
Kalinin V.V., Zheleznova E.V., Zemlyanaya A.A., Sokolova L.V., Subbotin K.Yu. DEPRESSIONS IN EPILEPSIA: PREVALENCE, RISK FACTORS, SYMPTOMS AND THERAPY. Epilepsy and paroxysmal conditions. 2017;9(3):47-53. (In Russ.) https://doi.org/10.17749/2077-8333.2017.9.3.047-053
Views: 688
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
